Clinical Trial Update: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating the 24-hour efficacy of Rotigotine for Parkinson's disease has completed, with results posted in 2010. Sponsorship is by U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Rotigotine (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-04-12